Tesa/Ipa 10mg is a dual-peptide research formulation containing Tesamorelin and Ipamorelin developed for controlled laboratory and analytical research applications.

This research blend is designed for scientific investigation involving growth hormone-related signaling pathways, GHRH mechanisms, GHSR receptor interactions, peptide-receptor activity, and molecular research models.

The combination of Tesamorelin and Ipamorelin provides researchers with a platform for studying dual-peptide interactions, receptor binding mechanisms, endocrine signaling pathways, and peptide pharmacology under controlled laboratory conditions.

Tesa/Ipa 10mg is supplied in lyophilized powder form and manufactured with a focus on consistency, quality standards, and reliable research supply. Each batch is supported with documentation for qualified research facilities.

This compound is intended strictly for research use only and is not approved for human consumption, therapeutic application, or diagnostic use.